11 results about "Dysuria" patented technology

The invention discloses a traditional Chinese medicine composition for treating uroschesis caused by benign prostatic hyperplasia and a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared by mixing leeches, radix semiaquilegiae, cortex phellodendri, rhizoma anemarrhenae, Chinese lobelia, polygonum cuspidatum, herba patriniae, dianthus superbus, cowherb seeds, lumbricus, pericarpium citri reticulatae viride and lindera aggregata and then decocting with water. According to the traditional Chinese medicine composition, treatment is carried out synergistically from the three aspects of rapid relieving of emergency symptoms, targeted treatment of pathologic roots and synchronous recovery of whole body metabolic balance, and the four-in-one comprehensive curative effect of diuretic, anti-male, anti-inflammatory and tissue repair is achieved; the traditional Chinese medicine composition is simple in preparation method, low in cost and wide in safety window, is applied to treatment of uroschesis caused by benign prostatic hyperplasia, and provides a family-friendly traditional Chinese medicine solution capable of replacing or being combined with existing chemical medicines for patients.

The utility model discloses a urethra stent tube, particularly relates to urethra stent tube technical field, including inner stent tube, outer stent tube no. 1 and outer stent tube no. 2, the both ends of inner stent tube take the shape of circle-shaped hook, the outer wall of both sides of inner stent tube is processed with a plurality of side hole no. 1, the outer wall of both sides of outer stent tube no. 1 is processed with a plurality of side hole no. A detachable waterproof film is arranged in the first outer support pipe, the bottom of the first outer support pipe is fixedly connected with an adapter, and the top of the second outer support pipe is fixedly connected with an adapter. By combining the inner stent tube, the first outer stent tube and the second outer stent tube, the inner stent tube plays a role in urine drainage and avoids dysuria or urinary retention caused by surgery and anesthesia in the early stage of a post-operation, the first outer stent tube can support the urethra and prevent urethra wound collapse and adhesion, and the first outer stent tube has no stimulation effect on the posterior urethra and the bladder, so that the urethra can be prevented from being damaged. Meanwhile, exudate at the wound can be discharged conveniently, and the second outer support tube can be connected with a drainage bag for use.

The invention provides an implantable balloon-shaped pressure valve assembly for urinary incontinence treatment, and belongs to the field of medical instruments. Comprising a balloon shell, a hard rod is arranged on the outer surface of the balloon shell, a pressure control module is fixedly connected to the top of the hard rod, and a valve assembly used for controlling the urinary tract to be closed is arranged on the inner surface of the balloon shell. The pressure detector can detect the pressure in the bladder in real time during working, when the pressure detector detects that the pressure reaches a threshold value, the pressure valve can be opened through the mobile phone terminal, the pressure valve controls the valve element to be opened, urine in the bladder is discharged, and when power failure occurs or the sensor breaks down, the pressure detector can detect the pressure in the bladder in real time. At the moment, a worm can be rotated to drive a rotating rod to rotate through a worm gear, the rotating rod drives a pressure valve to mechanically rotate, the pressure valve is manually opened, urination safety under extreme conditions is ensured, and safety and reliability of equipment are improved.

The invention relates to the technical field of traditional Chinese medicines, and particularly discloses a Miao medicine composition for prostate health care. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 10-20 parts of bulbophyllum, 8-15 parts of phryma leptostachya, 5-12 parts of sambucus chinensis, 3-8 parts of pseudo-ginseng and 2-6 parts of ethanol. The Miao medicine composition is prepared by the following steps: washing, drying and mixing the sambucus chinensis, the phryma leptostachya, the sambucus chinensis and the pseudo-ginseng, adding an ethanol water solution for soaking, and filtering to obtain an extracting solution, namely the Miao medicine composition. The Miao medicine composition can be used for relieving symptoms such as frequent micturition, urgent urination and unsmooth urination caused by benign prostatic hyperplasia and chronic inflammation, and can be used for improving local blood circulation and microcirculation; the powerful targeting effect on deep target tissue prostate is realized, so that the enhanced curative effect of treating both symptoms and root causes is achieved; the traditional Chinese medicine composition has the advantages of quick response, remarkable and lasting curative effect, high safety and good patient comfort and acceptability.

A urine exosome marker panel for detecting bladder cancer and the use thereof. The provided biomarker panel comprising IGF2, KRT20, SPAG5, NRP1 and DHRS2 is used for detecting bladder cancer patients. The marker panel is used to construct a prediction model, and the model is trained by means of a training set and optimized by means of a test verification set, so as to finally obtain an early diagnosis prediction model for bladder cancer. The provided exosome marker panel and prediction model enable relatively accurate early screening of clinical samples from patients clinically suspected of having bladder cancer, presenting with symptoms such as hematuria, frequent urination, urgent urination, and dysuria, and for whom cystoscopy is recommended by clinical diagnosis, wherein the optimal marker panel is IGF2+KRT20+SPAG5+NRP1, with an AUC of 0.902, a sensitivity of 86.8%, a specificity of 83.0%, and an accuracy of 84.8%, demonstrating favorable clinical diagnostic value.

1. The name of the design product: urinary catheter (urology). 2. The use of the design product: for guiding urine of incontinent patients or patients with dysuria. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: perspective view.

The invention relates to application of ergothioneine in preparation of a product for improving kidney health. The improvement of kidney health comprises any one or a combination of at least two of improvement of a kidney filtration function, reduction of kidney oxidative stress injury, improvement of urination discomfort and improvement of chronic kidney diseases. The invention develops a brand new application scene aiming at the ergothioneine, the ergothioneine has an excellent effect of improving and maintaining the kidney health, and further finds that the ergothioneine is combined with the L-theanine, the pyrroloquinoline quinone or the salt thereof to be used together, so that the ergothioneine has a more excellent effect in the aspect of improving the kidney health, and the three active ingredients promote each other, so that the effect of improving the kidney health is achieved. And an unexpected chain type synergistic effect can be obtained.

The application relates to a shrinking and lubricating gel, which comprises the following raw materials in percentage by weight: xanthan gum 0.1-2%, trehalose 0.1-2%, carbomer 0.1-3%, glycerol 1-20%, gelatin alginate complex 1-10%, humectant 0.2-4%, disodium edetate 0.01-0.1%, polyethylene glycol 0.1-2%, pH regulator 0.1-3%, royal jelly extract 0-2%, schisandra extract 0-2%, and the balance is water. The application forms a protective biological gel layer on the vaginal wall through the lubricating gel, so as to prevent pathogenic microorganisms from planting, and is suitable for improving itching, erosion, burning, vaginal atrophy, sexual intercourse pain, senile vaginitis, abnormal leucorrhea, urinary urgency, dysuria and other menopausal reproductive urological syndromes.

The application discloses a dysuria and urinary incontinence integrated monitoring and diagnosing system based on intelligent sensing, comprising: a bladder emptying evaluation module for real-time tracking of bladder shape and volume change and evaluation of whether the bladder is completely emptied; a detrusor contraction function evaluation module for real-time monitoring of the contraction strength and coordination of the detrusor and judgment of whether it works normally; a bladder pressure evaluation module for evaluation of bladder compliance and detrusor function by monitoring the elasticity change and pressure change of the bladder wall; a urinary flow rate determination module for real-time measurement of bladder shape change and urinary flow rate and evaluation of the urinary flow rate; a urethral obstruction and bladder outlet obstruction evaluation module for evaluation of whether there is obstruction in the urethra or bladder outlet by real-time monitoring of the shape change and pressure change of the bladder and urethra; and a data analysis and intelligent diagnosis module for providing dysuria diagnosis and treatment suggestion. The application not only improves the accuracy and operability of dysuria diagnosis, but also optimizes the clinical decision-making process.

The application discloses a kind of infusion type catheter device, including: catheter body, upper end is equipped with pressure sensor, water bag, urine inlet and one-way diaphragm, and inside is opened with catheter passage, infusion passage, water filling channel, lower part is equipped with catheter branch pipe, medicine branch pipe, infusion branch pipe, and the opening and closing control unit is arranged on catheter branch pipe, and the opening and closing control unit is electrically connected with pressure sensor.The application provides a kind of infusion type catheter device, when reaching the urination pressure value, then the opening and closing control unit on the lower part of catheter body catheter branch pipe is started, and the opening and closing control unit is started, and then urine is discharged into the urine bag in the lower end of catheter branch pipe through catheter passage, catheter branch pipe, so that patient can automatically urinate;Normal saline can be injected through infusion passage, and normal saline is then pushed open one-way diaphragm and enters into patient bladder, to prevent the formation of blood clot and cause patient dysuria, reduce the discomfort to patient body.

The present invention relates to a novel compound and a use thereof for treatment of dysuria, cough and erectile dysfunction. More specifically, the present invention relates to a novel diphenyl ether derivative compound capable of ameliorating and treating dysuria, cough, and erectile dysfunction related thereto by effectively activating a BKCa channel.